Credit Suisse, Autodesk And Other Big Losers From Wednesday
U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Venus Concept (NASDAQ:VERO) stock increased by 42.8% to $0.31 during Thursday’s regular session. As of 12:30 EST,…
JP Morgan Downgrades C4 Therapeutics to Neutral, Lowers Price Target to $15
JP Morgan analyst Eric Joseph downgrades C4 Therapeutics (NASDAQ:CCCC) from Overweight to Neutral and lowers the price target from $22 to $15.
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
Gainers
Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
C4 Therapeutics Q2 EPS $(0.56) Down From $(0.51) YoY, Sales $13.83M Up From $9.78M YoY
C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(0.56) per share. This is a 9.8 percent decrease over losses of $(0.51) per share from the same period last year. The company reported $13.83 million in sales
C4 Therapeutics Doses First Patient in Phase 1/2 Trial of CFT8634 For SMARCB1-perturbed cancers
C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC) has dosed the first patient in the Phase 1/2 clinical trial of its drug candidate CFT8634, for the treatment of SMARCB1-perturbed cancers, including synovial sarcoma and SMARCB1-null tumors.
C4 Therapeutics Announces First Patient Dosed In Phase 1/2 Clinical Trial Evaluating CFT8634, An Orally Bioavailable BiDAC Degrader For The Treatment Of Synovial Sarcoma And SMARCB1-Null Tumors
C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
C4 Therapeutics: Q1 Earnings Insights
C4 Therapeutics (NASDAQ:CCCC) reported its Q1 earnings results on Thursday, May 5, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
31 Stocks Moving In Monday’s Mid-Day Session
Gainers
Redbox Entertainment Inc. (NASDAQ: RDBX) climbed 64.9% to $9.86. Redbox recently reported CFO transition.